
Tazoduke 4000mg/500mg Injection
Marketer
Swiss Pharma Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazoduke 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity and must be followed precisely. Report any persistent side effects, such as nausea, vomiting, diarrhea, rash, or injection site reactions (pain, swelling, redness), to your doctor. Prior to treatment, inform your doctor of any antibiotic allergies, kidney, or liver conditions; adjustments to the medication may be necessary. Generally safe for pregnant and breastfeeding individuals under medical guidance.
Uses of Tazoduke 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazoduke 4000mg/500mg Injection:
Administering this medication will be handled by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Tazoduke 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazoduke 4000mg/500mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Tazoduke 4000mg/500mg Injection works:
The injectable formulation Tazoduke, containing 4000mg of Piperacillin and 500mg of Tazobactum, employs a dual-drug mechanism. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance, thus optimizing Piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Tazoduke 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazoduke 4000mg/500mg is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The 4000mg/500mg Tazoduke injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no substantial danger to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazoduke 4000mg/500mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Tazoduke 4000mg/500mg Injection requires careful consideration. Dosage modification of Tazoduke 4000mg/500mg Injection may be necessary. Medical advice should be sought.
LiverSAFE IF PRESCRIBED
The use of Tazoduke 4000mg/500mg Injection in individuals with hepatic impairment appears to present a low risk. Existing evidence indicates dose modification for Tazoduke 4000mg/500mg Injection may be unnecessary in such cases. However, medical advice should always be sought.
What if you forget to take Tazoduke 4000mg/500mg Injection :
Omitting a scheduled dose of Tazoduke 4000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Tazoduke 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
